Brian Carrigan
Family Medicine · Blackfoot, IDNPI 1457300279
Payments from drug & device makers
Across 40 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$71
- AbbVie$67
- GSK$60
- Abbott$59
- Medtronic$40
- Dexcom, Inc.$39
- plus $364 from 17 others
What the payments were for
- Food & beverage$702100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 5 | $71 |
| AbbVie | 3 | $67 |
| GSK | 4 | $60 |
| Abbott | 3 | $59 |
| Medtronic | 2 | $40 |
| Dexcom, Inc. | 2 | $39 |
| Merck | 2 | $39 |
| Novartis | 2 | $37 |
| Lilly USA, LLC | 3 | $37 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Mylan Specialty L.p. | 1 | $20 |
| Boston Scientific | 1 | $18 |
| Edwards Lifesciences | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Amgen | 1 | $16 |
| Pfizer | 1 | $13 |
| Neurelis, Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $11 |
| Avanos Medical | 1 | $11 |
How this compares
$702 in reported general payments places this provider in the 65th percentile of 803 family medicine providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 21 | $21,266 |
| OzempicSemaglutide | 19 | $18,056 |
| XareltoRivaroxaban | 17 | $17,977 |
| TrulicityDulaglutide | 11 | $10,869 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $7,323 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $6,487 |
| Levothyroxine Sodium | 265 | $2,421 |
| Omeprazole | 221 | $1,957 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $1,167 |
| Atorvastatin Calcium | 146 | $1,146 |
| Amlodipine Besylate | 275 | $860 |
| Escitalopram Oxalate | 69 | $650 |
| Enalapril Maleate | 98 | $634 |
| Memantine Hcl | 15 | $518 |
| Tamsulosin Hcl | 51 | $461 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $37 | $32,13532 claims |
| Novo NordiskOzempic | $71 | $18,05619 claims |
| GSKTrelegy Ellipta | $60 | $7,32311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 803 family medicine providers in Idaho.
Other family medicine in Blackfoot
- Gary SoucieBlackfoot$5.8M
- Paul BeckettBlackfoot$344K
- Matthew FackrellBlackfoot$5K
- Mark TurnerMeridian$40.5M
- David ButukMeridian$15.2M
- Brock McConneheyBoise$4.5M
- William LaitinenMiddleton$1.1M
- Diane McConneheyBoise$681K
- Flint PackerIdaho Falls$587K
- Elaine DavidsonMeridian$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.